Opeyemi A Jagede (Opeyemi Jegede, Opeyemi A Jegede)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 26

Top Topics

Hodgkin Lymphoma

Diffuse Large B Cell Lymphoma

Renal Cell Carcinoma

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Cancer research communications

JCO precision oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Vered Stearns, Opeyemi A Jagede, Victor Tsu-Shih Chang, Todd C Skaar, Jeffrey L Berenberg, Ranveer Nand, Atif Shafqat, Nisha Lassi Jacobs, William Luginbuhl, Paul Gilman, Al Bowen Benson, Judie R Goodman, Gary L Buchschacher, Norah L Henry, Charles L Loprinzi, Patrick J Flynn, Edith P Mitchell, Michael Jordan Fisch, Joseph A Sparano, Lynne I Wagner
A Cohort Study to Evaluate Genetic Predictors of Aromatase Inhibitor Musculoskeletal Symptoms: Results from ECOG-ACRIN E1Z11. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (13) (2024)
Brad S Kahl, Opeyemi A Jagede, Christopher Peterson, Lode J Swinnen, Thomas M Habermann, Stephen J Schuster, Matthias Weiss, Paul A Fishkin, Timothy S Fenske, Michael E Williams
Long-Term Follow-Up of the RESORT Study (E4402): A Randomized Phase III Comparison of Two Different Rituximab Dosing Strategies for Low-Tumor Burden Follicular Lymphoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (7) (2024)
Brad S Kahl, Opeyemi A Jagede, Christopher Peterson, Lode J Swinnen, Thomas M Habermann, Stephen J Schuster, Matthias Weiss, Paul A Fishkin, Timothy S Fenske, Michael E Williams
Long-Term Follow-Up of the RESORT Study (E4402): A Randomized Phase III Comparison of Two Different Rituximab Dosing Strategies for Low-Tumor Burden Follicular Lymphoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Edgar G Kozlova, Hsin-Hui Huang, Opeyemi A Jagede, Kevin Tuballes, Diane M Del Valle, Geoffrey Kelly, Manishkumar Patel, Hui Xie, Jocelyn Harris, Kimberly Argueta, Kai Nie, Vanessa Barcessat, Radim Moravec, Jennifer Altreuter, Dzifa Yawa Duose, Brad S Kahl, Stephen M Ansell, Joyce Yu, Ethan Cerami, James R Lindsay, Ignacio I Wistuba, Seunghee Kim-Schulze, Catherine S Diefenbach, Sacha Gnjatic
Tumor-Immune Signatures of Treatment Resistance to Brentuximab Vedotin with Ipilimumab and/or Nivolumab in Hodgkin Lymphoma. Cancer research communications 4 (7) (2024)
Brad S Kahl, Opeyemi A Jagede, Christopher Peterson, Lode J Swinnen, Thomas M Habermann, Stephen J Schuster, Matthias Weiss, Paul A Fishkin, Timothy S Fenske, Michael E Williams
Long-Term Follow-Up of the RESORT Study (E4402): A Randomized Phase III Comparison of Two Different Rituximab Dosing Strategies for Low-Tumor Burden Follicular Lymphoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (7) (2024)
Vered Stearns, Opeyemi A Jagede, Victor Tsu-Shih Chang, Todd C Skaar, Jeffrey L Berenberg, Ranveer Nand, Atif Shafqat, Nisha Lassi Jacobs, William Luginbuhl, Paul Gilman, Al Bowen Benson, Judie R Goodman, Gary L Buchschacher, Norah L Henry, Charles L Loprinzi, Patrick J Flynn, Edith P Mitchell, Michael Jordan Fisch, Joseph A Sparano, Lynne I Wagner
A Cohort Study to Evaluate Genetic Predictors for Aromatase Inhibitor Musculoskeletal Symptoms (AIMSS): Results from ECOG-ACRIN E1Z11. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Edgar G Kozlova, Hsin-Hui Huang, Opeyemi A Jagede, Kevin Tuballes, Diane M Del Valle, Geoffrey Kelly, Manishkumar Patel, Hui Xie, Jocelyn Harris, Kimberly Argueta, Kai Nie, Vanessa Barcessat, Radim Moravec, Jennifer Altreuter, Dzifa Yawa Duose, Brad S Kahl, Stephen M Ansell, Joyce Yu, Ethan Cerami, James R Lindsay, Ignacio I Wistuba, Seunghee Kim-Schulze, Catherine S Diefenbach, Sacha Gnjatic
Tumor-immune signatures of treatment resistance to brentuximab vedotin with ipilimumab and/or nivolumab in Hodgkin lymphoma. Cancer research communications (2024)
Vered Stearns, Opeyemi A Jagede, Victor Tsu-Shih Chang, Todd C Skaar, Jeffrey L Berenberg, Ranveer Nand, Atif Shafqat, Nisha Lassi Jacobs, William Luginbuhl, Paul Gilman, Al Bowen Benson, Judie R Goodman, Gary L Buchschacher, Norah L Henry, Charles L Loprinzi, Patrick J Flynn, Edith P Mitchell, Michael Jordan Fisch, Joseph A Sparano, Lynne I Wagner
A Cohort Study to Evaluate Genetic Predictors of Aromatase Inhibitor Musculoskeletal Symptoms: Results from ECOG-ACRIN E1Z11. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (13) (2024)
Vered Stearns, Opeyemi A Jagede, Victor Tsu-Shih Chang, Todd C Skaar, Jeffrey L Berenberg, Ranveer Nand, Atif Shafqat, Nisha Lassi Jacobs, William Luginbuhl, Paul Gilman, Al Bowen Benson, Judie R Goodman, Gary L Buchschacher, Norah L Henry, Charles L Loprinzi, Patrick J Flynn, Edith P Mitchell, Michael Jordan Fisch, Joseph A Sparano, Lynne I Wagner
A Cohort Study to Evaluate Genetic Predictors of Aromatase Inhibitor Musculoskeletal Symptoms: Results from ECOG-ACRIN E1Z11. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (13) (2024)
Vered Stearns, Opeyemi A Jagede, Victor Tsu-Shih Chang, Todd C Skaar, Jeffrey L Berenberg, Ranveer Nand, Atif Shafqat, Nisha Lassi Jacobs, William Luginbuhl, Paul Gilman, Al Bowen Benson, Judie R Goodman, Gary L Buchschacher, Norah L Henry, Charles L Loprinzi, Patrick J Flynn, Edith P Mitchell, Michael Jordan Fisch, Joseph A Sparano, Lynne I Wagner
A Cohort Study to Evaluate Genetic Predictors of Aromatase Inhibitor Musculoskeletal Symptoms: Results from ECOG-ACRIN E1Z11. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (13) (2024)
Vered Stearns, Opeyemi A Jagede, Victor Tsu-Shih Chang, Todd C Skaar, Jeffrey L Berenberg, Ranveer Nand, Atif Shafqat, Nisha Lassi Jacobs, William Luginbuhl, Paul Gilman, Al Bowen Benson, Judie R Goodman, Gary L Buchschacher, Norah L Henry, Charles L Loprinzi, Patrick J Flynn, Edith P Mitchell, Michael Jordan Fisch, Joseph A Sparano, Lynne I Wagner
A Cohort Study to Evaluate Genetic Predictors of Aromatase Inhibitor Musculoskeletal Symptoms: Results from ECOG-ACRIN E1Z11. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (13) (2024)
Brad S Kahl, Opeyemi A Jagede, Christopher Peterson, Lode J Swinnen, Thomas M Habermann, Stephen J Schuster, Matthias Weiss, Paul A Fishkin, Timothy S Fenske, Michael E Williams
Long-Term Follow-Up of the RESORT Study (E4402): A Randomized Phase III Comparison of Two Different Rituximab Dosing Strategies for Low-Tumor Burden Follicular Lymphoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (7) (2024)
Edgar G Kozlova, Hsin-Hui Huang, Opeyemi A Jagede, Kevin Tuballes, Diane M Del Valle, Geoffrey Kelly, Manishkumar Patel, Hui Xie, Jocelyn Harris, Kimberly Argueta, Kai Nie, Vanessa Barcessat, Radim Moravec, Jennifer Altreuter, Dzifa Yawa Duose, Brad S Kahl, Stephen M Ansell, Joyce Yu, Ethan Cerami, James R Lindsay, Ignacio I Wistuba, Seunghee Kim-Schulze, Catherine S Diefenbach, Sacha Gnjatic
Tumor-Immune Signatures of Treatment Resistance to Brentuximab Vedotin with Ipilimumab and/or Nivolumab in Hodgkin Lymphoma. Cancer research communications 4 (7) (2024)
Mitchell Reed Smith, Opeyemi A Jagede, Peter Martin, Brian Till, Samir Parekh, David T Yang, Eric D Hsi, Thomas E Witzig, Sandeep S Dave, David W Scott, Curtis A Hanson, Lale Kostakoglu, Nizar N Abdel Samad, Carla Casulo, Nancy L Bartlett, Paolo F Caimi, Tareq Al Baghdadi, Kristie Blum, Mark Romer, David J Inwards, Rachel Lerner, Lynne I Wagner, Richard F Little, Jonathan W Friedberg, John P Leonard, Brad S Kahl
Randomized Bendamustine-Rituximab(R) + Bortezomib Induction and R + Lenalidomide Maintenance for Mantle Cell Lymphoma. Blood (2024)
Vered Stearns, Opeyemi A Jagede, Victor Tsu-Shih Chang, Todd C Skaar, Jeffrey L Berenberg, Ranveer Nand, Atif Shafqat, Nisha Lassi Jacobs, William Luginbuhl, Paul Gilman, Al Bowen Benson, Judie R Goodman, Gary L Buchschacher, Norah L Henry, Charles L Loprinzi, Patrick J Flynn, Edith P Mitchell, Michael Jordan Fisch, Joseph A Sparano, Lynne I Wagner
A Cohort Study to Evaluate Genetic Predictors of Aromatase Inhibitor Musculoskeletal Symptoms: Results from ECOG-ACRIN E1Z11. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (13) (2024)
Edgar G Kozlova, Hsin-Hui Huang, Opeyemi A Jagede, Kevin Tuballes, Diane M Del Valle, Geoffrey Kelly, Manishkumar Patel, Hui Xie, Jocelyn Harris, Kimberly Argueta, Kai Nie, Vanessa Barcessat, Radim Moravec, Jennifer Altreuter, Dzifa Yawa Duose, Brad S Kahl, Stephen M Ansell, Joyce Yu, Ethan Cerami, James R Lindsay, Ignacio I Wistuba, Seunghee Kim-Schulze, Catherine S Diefenbach, Sacha Gnjatic
Tumor-Immune Signatures of Treatment Resistance to Brentuximab Vedotin with Ipilimumab and/or Nivolumab in Hodgkin Lymphoma. Cancer research communications 4 (7) (2024)
Vered Stearns, Opeyemi A Jagede, Victor Tsu-Shih Chang, Todd C Skaar, Jeffrey L Berenberg, Ranveer Nand, Atif Shafqat, Nisha Lassi Jacobs, William Luginbuhl, Paul Gilman, Al Bowen Benson, Judie R Goodman, Gary L Buchschacher, Norah L Henry, Charles L Loprinzi, Patrick J Flynn, Edith P Mitchell, Michael Jordan Fisch, Joseph A Sparano, Lynne I Wagner
A Cohort Study to Evaluate Genetic Predictors of Aromatase Inhibitor Musculoskeletal Symptoms: Results from ECOG-ACRIN E1Z11. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (13) (2024)
Brad S Kahl, Opeyemi A Jagede, Christopher Peterson, Lode J Swinnen, Thomas M Habermann, Stephen J Schuster, Matthias Weiss, Paul A Fishkin, Timothy S Fenske, Michael E Williams
Long-Term Follow-Up of the RESORT Study (E4402): A Randomized Phase III Comparison of Two Different Rituximab Dosing Strategies for Low-Tumor Burden Follicular Lymphoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (7) (2024)
Thomas Denize, Opeyemi A Jagede, Sayed Matar, Nourhan El Ahmar, Destiny J West, Emily Walton, Aseman Sheshdeh Bagheri, Varunika Savla, Yasmin Nabil Laimon, Saurabh Gupta, Sai Vikram Vemula, David A Braun, Kelly P Burke, Paul J Catalano, Gordon J Freeman, Robert J Motzer, Michael B Atkins, David F McDermott, Arlene H Sharpe, Toni K Choueiri, Sabina Signoretti
PD-1 Expression on Intratumoral Regulatory T Cells is Associated with Lack of Benefit from Anti-PD-1 Therapy in Metastatic Clear Cell Renal Cell Carcinoma Patients. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Michael B Atkins, Opeyemi A Jagede, Naomi B Haas, David F McDermott, Mehmet A Bilen, Mark N Stein, Jeffrey A Sosman, Robert Alter, Elizabeth R Plimack, Moshe C Ornstein, Michael E Hurwitz, David J Peace, Sabina Signoretti, Thomas Denize, Alessia Cimadamore, Catherine J Wu, David A Braun, David J Einstein, Paul J Catalano, Hans Hammers
Phase II Study of Nivolumab and Salvage Nivolumab/Ipilimumab in Treatment-Naive Patients With Advanced Clear Cell Renal Cell Carcinoma (HCRN GU16-260-Cohort A). Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (25) (2022)
Ian E Krop, Opeyemi A Jagede, Juneko E Grilley Olson, Josh D Lauring, Edith P Mitchell, James A Zwiebel, Robert C Gray, Victoria Wang, Lisa Meier McShane, Lawrence V Rubinstein, David R Patton, P Mickey Williams, Stanley R Hamilton, Scott A Kono, James M Ford, Agustin A Garcia, Xingwei D Sui, Robert D Siegel, Brian M Slomovitz, Barbara A Conley, Carlos L Arteaga, Lyndsay N Harris, Peter J O'Dwyer, Alice P Chen, Keith T Flaherty
Phase II Study of Taselisib in PIK3CA -Mutated Solid Tumors Other Than Breast and Squamous Lung Cancer: Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol I. JCO precision oncology 6 (2022)
Meredith M Regan, Opeyemi A Jagede, Charlene M Mantia, Thomas Powles, Lillian Werner, Robert J Motzer, Nizar M Tannir, Chung-Han Lee, Yoshihiko Tomita, Martin H Voss, Elizabeth R Plimack, Toni K Choueiri, Brian I Rini, Hans J Hammers, Bernard Escudier, Laurence Albiges, Stephen Huo, Viviana Del Tejo, Brian Stwalley, Michael B Atkins, David F McDermott
Treatment-free Survival after Immune Checkpoint Inhibitor Therapy versus Targeted Therapy for Advanced Renal Cell Carcinoma: 42-Month Results of the CheckMate 214 Trial. Clinical cancer research : an official journal of the American Association for Cancer Research (2021)
Eddy Shih-Hsin Yang, Amin H Nassar, Elio Adib, Opeyemi A Jagede, Sarah Abou Alaiwi, Deborah L Della Manna, David A Braun, Mahsa Zarei, Heng Du, Sumanta K Pal, Gurudatta Naik, Guru P Sonpavde
Gene Expression Signature Correlates with Outcomes in Metastatic Renal Cell Carcinoma Patients Treated with Everolimus Alone or with a Vascular Disrupting Agent. Molecular cancer therapeutics 20 (8) (2021)
Miriam Ficial, Opeyemi A Jagede, Miriam Sant'Angelo, Yue Hou, Abdallah Flaifel, Jean-Christophe Pignon, David A Braun, Megan Wind-Rotolo, Maura A Sticco-Ivins, Paul J Catalano, Gordon J Freeman, Arlene H Sharpe, F Stephen Hodi, Robert J Motzer, Catherine J Wu, Michael B Atkins, David F McDermott, Sachet A Shukla, Toni K Choueiri, Sabina Signoretti
Expression of T-Cell Exhaustion Molecules and Human Endogenous Retroviruses as Predictive Biomarkers for Response to Nivolumab in Metastatic Clear Cell Renal Cell Carcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (5) (2020)
Leo L Tsai, Rupal S Bhatt, Meaghan F Strob, Opeyemi A Jagede, Maryellen R M Sun, David C Alsop, Paul J Catalano, David McDermott, Philip M Robson, Michael B Atkins, Ivan Pedrosa
Arterial Spin Labeled Perfusion MRI for the Evaluation of Response to Tyrosine Kinase Inhibition Therapy in Metastatic Renal Cell Carcinoma. Radiology 298 (2) (2020)
Rupal S Bhatt, Abdulla Berjis, Julie C Konge, Kathleen M Mahoney, Alyssa N Klee, Samuel S Freeman, Chun-Hau Chen, Opeyemi A Jagede, Paul J Catalano, Jean-Christophe Pignon, Maura Sticco-Ivins, Baogong Zhu, Ping Hua, Jo Soden, Jie Zhu, David F McDermott, Antonio R Arulanandam, Sabina Signoretti, Gordon J Freeman
KIR3DL3 Is an Inhibitory Receptor for HHLA2 that Mediates an Alternative Immunoinhibitory Pathway to PD1. Cancer immunology research 9 (2) (2020)